Results
4101
Companies which are more than 50% undervalued based on analyst price target.
4,101 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSTR | US$299.69 | -11.3% | 336.0% | US$83.4b | US$513.01 | PS166.4x | E57.1% | n/a | Software | ||
1299 | HK$58.00 | 3.0% | -10.4% | HK$618.4b | HK$92.77 | PE16.5x | E13.9% | 2.8% | Insurance | ||
4568 | JP¥3,429.00 | -6.0% | -30.3% | JP¥6.4t | JP¥6,216.67 | PE26.2x | E18.2% | 1.7% | Pharmaceuticals & Biotech | ||
AMMN | Rp7,275.00 | 6.6% | -9.1% | Rp527.6t | Rp12,000.00 | PE35.7x | E-25.7% | n/a | Materials | ||
A005380 | ₩206,000.00 | 0% | -15.6% | ₩45.5t | ₩312,300.69 | PE4x | E5.8% | 5.5% | Automobiles | ||
512599 | ₹2,135.40 | -0.8% | -34.6% | ₹2.5t | ₹3,855.00 | PE68.8x | E47.4% | 0.06% | Capital Goods | ||
A000270 | ₩94,600.00 | -0.4% | -20.1% | ₩36.9t | ₩142,785.71 | PE3.8x | E3.9% | 6.9% | Automobiles | ||
PRU | UK£7.15 | -1.6% | -12.7% | UK£18.8b | UK£11.31 | PE27.1x | E23.4% | 2.3% | Insurance | ||
EIX | US$52.17 | 4.2% | -23.6% | US$20.1b | US$78.34 | PE15.3x | E13.5% | 6.3% | Utilities | ||
601390 | CN¥5.81 | -2.7% | -9.6% | CN¥134.1b | CN¥8.78 | PE5.1x | E9.9% | 3.6% | Capital Goods | ||
300308 | CN¥118.73 | 10.5% | 12.5% | CN¥131.2b | CN¥192.85 | PE28.3x | E33.3% | 0.3% | Tech | ||
FSLR | US$155.44 | -2.7% | 8.8% | US$17.6b | US$266.76 | PE13.3x | E24.5% | n/a | Semiconductors | ||
27 | HK$29.50 | -0.8% | -32.1% | HK$129.0b | HK$45.10 | PE15.5x | E14.1% | 3.4% | Consumer Services | ||
IVN | CA$14.97 | -10.1% | 2.2% | CA$22.5b | CA$22.93 | PE61.8x | E52.7% | n/a | Materials | ||
ADANIGREEN | ₹849.35 | -4.0% | -55.8% | ₹1.3t | ₹1,613.00 | PE107.9x | E68.3% | n/a | Utilities | ||
ILMN | US$94.20 | -6.0% | -29.2% | US$15.4b | US$145.92 | PS3.4x | E52.3% | 3.3% | Pharmaceuticals & Biotech | ||
VWS | DKK 98.02 | -1.2% | -44.8% | DKK 98.6b | DKK 148.49 | PE26.5x | E22.3% | 0.5% | Capital Goods | ||
MRNA | US$35.53 | 7.7% | -63.2% | US$13.0b | US$56.51 | PS4.2x | E29.6% | n/a | Pharmaceuticals & Biotech | ||
RECLTD | ₹403.55 | 3.0% | -13.0% | ₹1.1t | ₹618.45 | PE6.8x | E10.5% | 5.0% | Diversified Financials | ||
JBSS3 | R$31.44 | -6.3% | 48.0% | R$68.7b | R$48.91 | PE9.6x | E2.3% | 9.5% | Food, Beverage & Tobacco | ||
601669 | CN¥5.00 | -2.7% | -2.3% | CN¥86.1b | CN¥8.80 | PE7x | E14.0% | 2.7% | Capital Goods | ||
SMPH | ₱23.70 | 3.0% | -28.6% | ₱684.4b | ₱35.79 | PE15.6x | E7.7% | 1.5% | Real Estate Management and Development | ||
2313 | HK$59.00 | -3.2% | -14.4% | HK$88.7b | HK$89.71 | PE15.4x | E12.1% | 4.1% | Consumer Durables | ||
NBIS | US$39.84 | -10.5% | n/a | US$10.9b | US$59.88 | PS79.8x | n/a | n/a | Software |